AC Immune SA (ACIU)
3.285
+0.04
(+1.39%)
USD |
NASDAQ |
Nov 21, 16:00
3.285
0.00 (0.00%)
After-Hours: 19:48
AC Immune Market Cap: 325.03M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 320.58M |
| November 19, 2024 | 323.54M |
| November 18, 2024 | 310.19M |
| November 15, 2024 | 315.63M |
| November 14, 2024 | 351.25M |
| November 13, 2024 | 309.69M |
| November 12, 2024 | 302.77M |
| November 11, 2024 | 313.65M |
| November 08, 2024 | 316.62M |
| November 07, 2024 | 323.54M |
| November 06, 2024 | 305.73M |
| November 05, 2024 | 320.58M |
| November 04, 2024 | 290.89M |
| November 01, 2024 | 296.83M |
| October 31, 2024 | 281.00M |
| October 30, 2024 | 293.86M |
| October 29, 2024 | 297.82M |
| October 28, 2024 | 296.83M |
| October 25, 2024 | 301.78M |
| October 24, 2024 | 296.83M |
| October 23, 2024 | 300.79M |
| October 22, 2024 | 307.71M |
| October 21, 2024 | 303.76M |
| October 18, 2024 | 309.69M |
| October 17, 2024 | 317.61M |
| Date | Value |
|---|---|
| October 16, 2024 | 315.63M |
| October 15, 2024 | 316.62M |
| October 14, 2024 | 315.63M |
| October 11, 2024 | 328.49M |
| October 10, 2024 | 330.47M |
| October 09, 2024 | 335.42M |
| October 08, 2024 | 327.50M |
| October 07, 2024 | 336.41M |
| October 04, 2024 | 334.43M |
| October 03, 2024 | 335.42M |
| October 02, 2024 | 344.32M |
| October 01, 2024 | 371.04M |
| September 30, 2024 | 374.00M |
| September 27, 2024 | 371.03M |
| September 26, 2024 | 366.08M |
| September 25, 2024 | 365.09M |
| September 24, 2024 | 368.06M |
| September 23, 2024 | 362.12M |
| September 20, 2024 | 365.09M |
| September 19, 2024 | 365.09M |
| September 18, 2024 | 359.15M |
| September 17, 2024 | 342.33M |
| September 16, 2024 | 323.53M |
| September 13, 2024 | 314.63M |
| September 12, 2024 | 301.77M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
143.47M
Minimum
Dec 22 2022
710.69M
Maximum
Jan 15 2020
371.09M
Average
353.02M
Median
Market Cap Benchmarks
| CRISPR Therapeutics AG | 3.952B |
| Addex Therapeutics Ltd | 8.795M |
| NLS Pharmaceutics Ltd | 12.93M |
| Molecular Partners AG | 196.71M |
| MoonLake Immunotherapeutics | 3.280B |
Market Cap Related Metrics
| Price to Book Value | 2.101 |
| Price to Free Cash Flow | 6.184 |
| Price | 3.285 |
| Earnings Yield | -13.97% |